CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BioSig Technologies Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BioSig Technologies Inc
55 Greens Farms Road
Phone: (203) 409-5444p:203 409-5444 WESTPORT, CT  06880  United States Ticker: BSGMBSGM
Business Summary
BioSig Technologies, Inc. is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is designed to pinpoint even the complex signals to maximize procedural success and efficiency. The PURE EP System is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes--Yes

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus
3829 Measuring and controlling devices, not elsewhere classified
3679 Electronic components, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Director, Principal Executive Officer AnthonyAmato 4/30/2024 4/30/2024
Interim Chief Financial Officer, Principal Accounting Officer, Vice President - Finance FerdinandGroenewald 39 6/5/2024 6/5/2024
Independent Director Steven E.Abelman 5/3/2024 5/3/2024
Independent Director ChrisBaer 55 5/2/2024 5/2/2024
Independent Director Donald F.Browne 5/3/2024 5/3/2024

Business Names
Business Name
BSGM
BSGMD
NeuroClear Technologies, Inc.
ViralClear Pharmaceuticals, Inc. Delaware

General Information
Number of Employees: 4 (As of 4/15/2024)
Outstanding Shares: 17,234,929 (As of 11/14/2024)
Shareholders: 392
Stock Exchange: NASD
Federal Tax Id: 264333375
Fax Number: (302) 645-1280


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024